摘要
目的探讨低分子肝素治疗急性冠状动脉综合征（ACS）的临床疗效。方法将70例ACS患者随即分为对照组和治疗组（各35例），疗程为7天。结果对照组总有效率为63％，治疗组总有效率为98％（P〈0．05）；治疗组缺血事件发生率明显低于对照组（P〈0．05）。结论在常规治疗的基础上加用低分子肝素，能使ACS得到有效控制，疗效显著、副作用少、安全可靠。
Objective To explore clinical therapeutic effective of low mdeculor Weight heparin in treating acute coronary syndrome. Methods 70 cases with acute coronary syndrome were randomly divided into the treating group （ normal treatment combined with low mdeculor weight heparin, n = 35 ） and control group（ normal treatment, n = 35 ）. The therapeutic course was 7 days. Result The total effective rate was 63% in control group and the total effective rate was 98% in treating group after 7 days （P 〈 0. 05 ）. Ischemic events occurent rate in treating group was significantly lower than that in control group （ P 〈 0. 05 ） ; and there was no obvious adverse reaction in treatment group. Conclusion Small dose of heparin combined with normal treatment can control ACS effectively.
关键词
低分子肝素
急性冠状动脉综合征
Low molecular weight heparln Acute coronary syndrome
